JP2020510656A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510656A5
JP2020510656A5 JP2019546401A JP2019546401A JP2020510656A5 JP 2020510656 A5 JP2020510656 A5 JP 2020510656A5 JP 2019546401 A JP2019546401 A JP 2019546401A JP 2019546401 A JP2019546401 A JP 2019546401A JP 2020510656 A5 JP2020510656 A5 JP 2020510656A5
Authority
JP
Japan
Prior art keywords
ala
val
phe
lys
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019546401A
Other languages
English (en)
Japanese (ja)
Other versions
JP7106560B2 (ja
JP2020510656A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/019874 external-priority patent/WO2018160539A1/en
Publication of JP2020510656A publication Critical patent/JP2020510656A/ja
Publication of JP2020510656A5 publication Critical patent/JP2020510656A5/ja
Priority to JP2022112146A priority Critical patent/JP7645843B2/ja
Application granted granted Critical
Publication of JP7106560B2 publication Critical patent/JP7106560B2/ja
Priority to JP2025033022A priority patent/JP2025087787A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019546401A 2017-02-28 2018-02-27 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート Active JP7106560B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022112146A JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762465118P 2017-02-28 2017-02-28
US62/465,118 2017-02-28
US201762480209P 2017-03-31 2017-03-31
US62/480,209 2017-03-31
PCT/US2018/019874 WO2018160539A1 (en) 2017-02-28 2018-02-27 Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022112146A Division JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Publications (3)

Publication Number Publication Date
JP2020510656A JP2020510656A (ja) 2020-04-09
JP2020510656A5 true JP2020510656A5 (https=) 2021-04-08
JP7106560B2 JP7106560B2 (ja) 2022-07-26

Family

ID=61617182

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019546401A Active JP7106560B2 (ja) 2017-02-28 2018-02-27 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2022112146A Active JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A Pending JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022112146A Active JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A Pending JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Country Status (13)

Country Link
US (3) US10792372B2 (https=)
EP (1) EP3589328A1 (https=)
JP (3) JP7106560B2 (https=)
KR (3) KR20250171447A (https=)
CN (3) CN116785451A (https=)
AU (2) AU2018229277B2 (https=)
CA (1) CA3054608A1 (https=)
IL (4) IL298414B2 (https=)
MA (1) MA47815A (https=)
RU (2) RU2765098C2 (https=)
SG (2) SG11201907693VA (https=)
TW (3) TWI781145B (https=)
WO (1) WO2018160539A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL281714B2 (en) 2011-04-01 2023-11-01 Immunogen Inc Methods for increasing the effectiveness of FOLR1 cancer therapy
KR20250114431A (ko) 2016-11-08 2025-07-29 리제너론 파마슈티칼스 인코포레이티드 스테로이드 및 이의 단백질-접합체
KR20250171447A (ko) 2017-02-28 2025-12-08 이뮤노젠 아이엔씨 자기희생적 펩티드 링커 및 이들의 접합체를 갖는 메이탄시노이드 유도체
KR20250008984A (ko) 2017-05-18 2025-01-16 리제너론 파마슈티칼스 인코포레이티드 사이클로덱스트린 단백질 약물 접합체
MX2020004691A (es) 2017-11-07 2020-08-20 Regeneron Pharma Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
CN112533951A (zh) 2018-05-09 2021-03-19 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
WO2020014306A1 (en) * 2018-07-10 2020-01-16 Immunogen, Inc. Met antibodies and immunoconjugates and uses thereof
CN111228508B (zh) * 2018-11-29 2023-02-17 暨南大学 一种多靶点抗肿瘤的多肽药物偶联物及其制备方法与应用
US11833214B2 (en) 2019-03-21 2023-12-05 Immunogen, Inc. Methods of preparing cell-binding agent-drug conjugates
WO2020223221A1 (en) * 2019-04-29 2020-11-05 Immunogen, Inc. Biparatopic fr-alpha antibodies and immunoconjugates
WO2024059263A1 (en) * 2022-09-15 2024-03-21 Immunogen, Inc. Methods for preparing maytansinoid derivatives with self-immolative peptide linkers
WO2025078841A2 (en) 2023-10-11 2025-04-17 Antikor Biopharma Limited Antibodies, conjugates, and uses thereof
WO2025094146A1 (en) 2023-11-02 2025-05-08 Immunogen Switzerland Gmbh Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
CN119661863B (zh) * 2024-12-11 2025-12-19 嘉庚创新实验室 一种双重刺激响应性的聚硫辛酸类聚合物、纳米递送体系及其制备方法和应用

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010129A (en) 1934-09-26 1935-08-06 Ingersoll Rand Co Valve assembly
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
ES2149768T3 (es) 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US20080152586A1 (en) 1992-09-25 2008-06-26 Avipep Pty Limited High avidity polyvalent and polyspecific reagents
US6355780B1 (en) 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
ES2194209T3 (es) 1996-07-22 2003-11-16 Monsanto Co Inhibidores de metaloproteasa de tiol sulfona.
CA2297070A1 (en) 1997-08-01 1999-02-11 Morphosys Ag Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
ES2276708T3 (es) 1999-11-24 2007-07-01 Immunogen, Inc. Agentes citotoxicos que comprenden taxanos y su uso terapeutico.
ATE367374T1 (de) 2000-07-19 2007-08-15 Mitsubishi Pharma Corp Sulphonsäurederivate von hydroxamsäuren und deren verwendung in medizinischen produkten
DE60140474D1 (de) 2000-09-08 2009-12-24 Univ Zuerich Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US20030109682A1 (en) * 2001-09-07 2003-06-12 Daniel Santi Maytansines and maytansine conjugates
WO2003034903A2 (en) 2001-10-23 2003-05-01 Psma Development Company, L.L.C. Psma antibodies and protein multimers
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en) 2002-04-05 2004-06-29 Immunogen, Inc. Prodrugs of CC-1065 analogs
CN100522955C (zh) 2002-08-02 2009-08-05 伊缪诺金公司 含有新型强效紫杉烷的细胞毒性剂及其治疗用途
JP2006500364A (ja) 2002-08-16 2006-01-05 イムノージェン インコーポレーテッド 高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
BR0316101A (pt) 2002-11-07 2005-09-27 Immunogen Inc Anticorpos anticd33 e processo para tratamento de leucemia melóide aguda usando os mesmos
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
PL3524611T3 (pl) 2003-05-20 2021-06-14 Immunogen, Inc. Udoskonalone czynniki cytotoksyczne zawierające nowe maitansynoidy
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
EA014640B1 (ru) 2003-07-21 2010-12-30 Иммьюноджен, Инк. Антитело или его эпитоп-связывающий фрагмент, которые связываются с гликотопом са6, и способы их применения
EP3225633B1 (en) 2004-05-21 2020-03-25 The UAB Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
KR20120064120A (ko) 2004-06-01 2012-06-18 제넨테크, 인크. 항체 약물 접합체 및 방법
EP1817341A2 (en) 2004-11-29 2007-08-15 Seattle Genetics, Inc. Engineered antibodies and immunoconjugates
BRPI0613593A2 (pt) 2005-07-08 2011-01-18 Univ Zuerich método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo
MX2008002607A (es) 2005-08-22 2008-03-19 Immunogen Inc Un conjugado citotoxico ca6 antigeno-especifico y metodos para utilizar el mismo.
WO2007062466A1 (en) 2005-11-29 2007-06-07 The University Of Sydney Demibodies: dimerisation-activated therapeutic agents
US7897568B2 (en) 2006-03-03 2011-03-01 Vinay K. Singh Compositions for treatment of cancer
ES2567402T3 (es) 2006-05-30 2016-04-22 Genentech, Inc. Anticuerpos anti CD22, sus inmunoconjugados y usos de los mismos
CA2655379A1 (en) 2006-06-22 2007-12-27 Walter And Eliza Hall Institute Of Medical Research Structure of the insulin receptor ectodomain
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
KR20200058590A (ko) 2008-04-30 2020-05-27 이뮤노젠 아이엔씨 가교제 및 그 용도
EP2276506A4 (en) 2008-04-30 2014-05-07 Immunogen Inc EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
BRPI0919881B1 (pt) 2008-10-31 2021-09-08 Centocor Ortho Biotech Inc Proteína de arcabouço e seu método de geração, biblioteca e seu método de construção, molécula de ácido nucleico, vetor de ácido nucleico, célula hospedeira, composição, dispositivo médico e artigo de fabricação
GB0913775D0 (en) 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
BRPI1008532B1 (pt) 2009-02-12 2021-12-14 Janssen Biotech, Inc Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos
SG181814A1 (en) 2009-12-23 2012-07-30 Avipep Pty Ltd Immuno-conjugates and methods for producing them 2
CN103037900B (zh) 2010-02-24 2016-04-06 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
SG183542A1 (en) 2010-03-12 2012-10-30 Immunogen Inc Cd37-binding molecules and immunoconjugates thereof
EP3569256B1 (en) 2010-04-30 2022-06-15 Janssen Biotech, Inc. Stabilized fibronectin domain compositions, methods and uses
CN103298489A (zh) 2010-10-29 2013-09-11 伊缪诺金公司 新型egfr结合分子及其免疫偶联物
CN105399831A (zh) 2010-10-29 2016-03-16 伊缪诺金公司 非拮抗性egfr结合分子及其免疫偶联物
RS58367B1 (sr) * 2011-03-29 2019-03-29 Immunogen Inc Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
IL281714B2 (en) 2011-04-01 2023-11-01 Immunogen Inc Methods for increasing the effectiveness of FOLR1 cancer therapy
CN103648532A (zh) * 2011-06-21 2014-03-19 伊缪诺金公司 具有肽连接子的新型美登木素生物碱衍生物及其偶联物
NL2009825C2 (en) 2012-11-16 2014-05-21 Ipee Bvba Sanitary appliance and method of determining use thereof.
CN104688740A (zh) * 2012-12-21 2015-06-10 百奥泰生物科技(广州)有限公司 类美登素衍生物及其制备方法和用途
KR102447350B1 (ko) * 2013-02-08 2022-09-23 노파르티스 아게 면역접합체의 제조를 위한 항체의 변형에 사용되는 특정 부위
WO2014134486A2 (en) * 2013-02-28 2014-09-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014176284A1 (en) * 2013-04-22 2014-10-30 Avelas Biosciences, Inc. Selective drug delivery compositions and methods of use
WO2014194030A2 (en) * 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2015038426A1 (en) * 2013-09-13 2015-03-19 Asana Biosciences, Llc Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
JP6701077B2 (ja) 2013-12-19 2020-05-27 シアトル ジェネティックス, インコーポレイテッド 標的化薬物結合体と使用するためのメチレンカルバメートリンカー
WO2015187428A1 (en) * 2014-06-06 2015-12-10 Redwood Bioscience, Inc. Anti-her2 antibody-maytansine conjugates and methods of use thereof
TW201609152A (zh) * 2014-09-03 2016-03-16 免疫原公司 包含細胞結合劑及細胞毒性劑之偶聯物
EA201791203A1 (ru) 2014-12-08 2018-04-30 Сорренто Терапьютикс, Инк. ЛЕКАРСТВЕННЫЙ КОНЪЮГАТ АНТИТЕЛА ПРОТИВ с-МЕТ
ES2887273T3 (es) 2015-06-29 2021-12-22 Immunogen Inc Anticuerpos anti-CD123 y conjugados y derivados de los mismos
KR20250171447A (ko) 2017-02-28 2025-12-08 이뮤노젠 아이엔씨 자기희생적 펩티드 링커 및 이들의 접합체를 갖는 메이탄시노이드 유도체
WO2020014306A1 (en) 2018-07-10 2020-01-16 Immunogen, Inc. Met antibodies and immunoconjugates and uses thereof

Similar Documents

Publication Publication Date Title
JP2020510656A5 (https=)
KR102923527B1 (ko) 생체활성 분자 접합체, 이의 제조 방법 및 용도
JP7645843B2 (ja) 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP7402807B2 (ja) グリピカン3抗体およびそのコンジュゲート
CN107530422B (zh) Cd48抗体和其缀合物
CN110240654A (zh) 结合cd73的抗体-药物偶联物
JP2017529837A (ja) 細胞結合剤及び細胞毒性剤を含む複合体
WO2018036243A1 (zh) 靶向于组织因子的抗体-药物偶联物
TWI827575B (zh) 苯二氮平衍生物
CA3084495A1 (en) Humanized anti-liv1 antibodies for the treatment of breast cancer
JP2022547434A (ja) 標的化デンドリマー複合体
TWI845724B (zh) 用於偶聯的多肽複合物及其應用
CN107614488A (zh) 新型亲水连接体和其在配体‑药物共轭偶联物上的应用
CN115768484A (zh) 含有抗ceacam5抗体缀合物和伊立替康的抗肿瘤组合
JP2023529640A (ja) 治療用コンジュゲート
JP2024509891A (ja) 抗her2抗体-免疫アゴニストコンジュゲート及びその使用
CN115427082A (zh) 含有抗ceacam5抗体缀合物和folfox的抗肿瘤组合
CN115484989A (zh) 含有抗ceacam5抗体缀合物、曲氟尿苷和三氟尿嘧啶的抗肿瘤组合
JP2025533983A (ja) リンカー-ペイロード化合物、複合体、及びその用途
JP2025532285A (ja) 高安定性親水性リンカーユニットを有するアウリスタチン系薬物及びその複合体
CN120774988A (zh) 一种连接子、抗体药物偶联物及其制备方法
JPWO2023104188A5 (https=)
HK1248538B (zh) Cd48抗体和其缀合物